Showing results (61-70 of 137) with videos related to
Sort By:
Pageof 14
Pediatric Hematology and Oncology|August 18, 2012
Clinical and immunological correction of DOCK8 deficiency by allogeneic hematopoietic stem cell transplantation following a reduced toxicity conditioning regimenHeidrun Boztug, Cäcilia Karitnig-Weiß, Bernd Ausserer, et al.International Journal of Cancer|April 3, 2020
Prognostic impact of distinct genetic entities in pediatric diffuse glioma WHO-grade II-Report from the German/Swiss SIOP-LGG 2004 cohortFabian Falkenstein, Marco Gessi, Daniela Kandels, et al.The Journal of Allergy and Clinical Immunology|January 25, 2017
Myb-like, SWIRM, and MPN domains 1 (MYSM1) deficiency: Genotoxic stress-associated bone marrow failure and developmental aberrationsEhsan Bahrami, Maximilian Witzel, Tomas Racek, et al.The Journal of Allergy and Clinical Immunology|December 17, 2009
ORAI1 deficiency and lack of store-operated Ca2+ entry cause immunodeficiency, myopathy, and ectodermal dysplasiaChristie-Ann McCarl, Capucine Picard, Sara Khalil, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 9, 2018
Haploidentical Stem Cell Transplantation for Refractory/Relapsed NeuroblastomaToni Illhardt, Jacek Toporski, Tobias Feuchtinger, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 2, 2020
Towards homogenization of total body irradiation practices in pediatric patients across SIOPE affiliated centers. A survey by the SIOPE radiation oncology working groupBianca A W Hoeben, Montserrat Pazos, Michael H Albert, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trialPeter Bader, Hermann Kreyenberg, Arend von Stackelberg, et al.Blood|January 25, 2015
Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCTJudith Feucht, Kathrin Opherk, Peter Lang, et al.Journal of Clinical Immunology|August 21, 2024
Allogeneic Hematopoietic Stem Cell Transplantation in Immunodeficiency-Centromeric Instability-Facial Dysmorphism (ICF) Syndrome: an EBMT/ESID Inborn Errors Working Party StudyDagmar Berghuis, Lubna S Mehyar, Rolla Abu-Arja, et al.Human Mutation|December 3, 2009
The most frequent DCLRE1C (ARTEMIS) mutations are based on homologous recombination eventsUlrich Pannicke, Manfred Hönig, Ilka Schulze, et al.Pageof 14